[Cardiac markers in the pericardial fluid in sudden coronary death]

Insights

Pericardial fluid analysis revealed elevated cardiac markers, including aspartate aminotransferase (AsAT), lactate dehydrogenase (LDG), and cardiac troponin I (cTnI), in patients who died from ischemic heart disease (IHD). These findings confirm the cardiac origin of these enzymes.

Area of Science:

  • Biochemistry
  • Cardiology
  • Pathology

Context:

  • Sudden cardiac death due to ischemic heart disease (IHD) presents diagnostic challenges.
  • Pericardial fluid analysis offers a potential window into cardiac injury.
  • Understanding enzyme release mechanisms in myocardial damage is crucial.

Purpose:

  • To investigate the presence and activity of cardiac markers in pericardial fluid of patients who died from IHD.
  • To compare these markers with a control group who died from non-cardiac causes.
  • To elucidate the origin and potential mechanisms of enzyme elevation in the pericardial fluid.

Summary:

  • Cardiac markers including aspartate aminotransferase (AsAT), lactate dehydrogenase (LDG) and its isoenzymes, and cardiac troponin I (cTnI) were measured in pericardial fluid from IHD patients and controls.
  • Statistically significant differences were observed in AsAT, LDG (particularly LDG1 and LDG2 predominance), and cTnI levels between groups.
  • Creatine kinase (CK) and its isoenzyme CK-MB showed no significant differences, suggesting specific enzyme release patterns.

Impact:

  • The study confirms the cardiac origin of enzymes found in pericardial fluid, supporting its utility in diagnosing cardiac events.
  • Findings provide insights into the mechanisms of enzyme release during ischemic myocardial damage.
  • This research may contribute to developing novel diagnostic strategies for acute cardiac conditions.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...